Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

British Medical Journal

Volumn 308, Issue 6921, 1994, Pages 81-106

  Altman, R ^a   Carreras, L ^a   Diaz, R ^a   Figueroa, E ^a   Paolasso, E ^a   Parodi, J C ^a   Cade, J F ^a   Donnan, G ^a   Eadie, M J ^a   Gavaghan, T P ^a   O'Sullivan, E F ^a   Parkin, D ^a   Renny, J T G ^a   Silagy, C ^a   Vinazzer, H ^a   Zekert, F ^a   Adriaensen, H ^a   Bertrand Hardy, J M ^a   Bran, M ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE; SULFINPYRAZONE; SULOCTIDIL; TICLOPIDINE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; STROKE;

CAUSE OF DEATH; CEREBROVASCULAR DISORDERS; HUMANS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; RISK FACTORS; TIME FACTORS;

EID: 0028120906     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)